Central Garden & Pet Company
Central Garden & Pet Company (CENT) Financial Performance & Income Statement Overview
Explore the financials of Central Garden & Pet Company (CENT), including yearly and quarterly data on income, cash flow, and balance sheets.
Central Garden & Pet Company (CENT) Income Statement & Financial Overview
Explore comprehensive income reports for Central Garden & Pet Company CENT, broken down by year and quarter.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $833.54M | $656.44M | $669.49M | $996.35M |
| Cost of Revenue | $560.45M | $460.74M | $500.54M | $679.29M |
| Gross Profit | $273.08M | $195.70M | $168.95M | $317.06M |
| Gross Profit Ratio | $0.33 | $0.30 | $0.25 | $0.32 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $179.76M | $167.71M | $201.36M | $190.52M |
| Operating Expenses | $179.76M | $167.71M | $201.36M | $201.12M |
| Total Costs & Expenses | $740.21M | $628.44M | $701.90M | $880.41M |
| Interest Income | $5.15M | $6.74M | $7.64M | $4.50M |
| Interest Expense | $14.51M | $14.47M | $14.12M | $14.72M |
| Depreciation & Amortization | $20.65M | $21.93M | $22.74M | $22.71M |
| EBITDA | $119.87M | $54.95M | -$8.17M | $143.38M |
| EBITDA Ratio | $0.14 | $0.08 | -$0.01 | $0.14 |
| Operating Income | $93.32M | $27.99M | -$32.41M | $115.94M |
| Operating Income Ratio | $0.11 | $0.04 | -$0.05 | $0.12 |
| Other Income/Expenses (Net) | -$8.61M | -$9.45M | -$12.61M | -$9.99M |
| Income Before Tax | $84.71M | $18.55M | -$45.02M | $105.94M |
| Income Before Tax Ratio | $0.10 | $0.03 | -$0.07 | $0.11 |
| Income Tax Expense | $19.90M | $4.36M | -$10.62M | $25.47M |
| Net Income | $63.63M | $14.009M | -$34.16M | $79.72M |
| Net Income Ratio | $0.08 | $0.02 | -$0.05 | $0.08 |
| EPS | $0.99 | $0.22 | -$2.16 | $1.21 |
| Diluted EPS | $0.98 | $0.21 | -$2.13 | $1.19 |
| Weighted Avg Shares Outstanding | $64.14M | $64.55M | $65.94M | $65.85M |
| Weighted Avg Shares Outstanding (Diluted) | $64.88M | $65.45M | $66.86M | $66.94M |
Financial performance has remained strong, with revenue growing from $996.35M in Q3 2024 to $833.54M in Q2 2025. Gross profit continued to perform well, with margins at 33% in the latest quarter. Operating income reached $93.32M in Q2 2025, holding a steady 11% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $119.87M. Net income rose to $63.63M, keeping EPS at $0.99. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan